Search Results
Jan 08, 2026, 03:42 ET Foresee Pharmaceuticals announces Global Licensing Agreement for MMP-12 Inhibitors with Primevera Therapeutics LLC
profitability.This strategic move marks a transformative milestone for Foresee, enabling the company to streamline operations and prioritizes its SIF (Stabilized Injectable Formulation) portfolio. Foresee is at a pivotal junction in its growth trajectory, and intends on building its revenue stream
More news about: Foresee Pharmaceuticals Co., Ltd.
Dec 24, 2025, 08:04 ET Foresee Pharmaceuticals announces the Casppian Phase 3 Study Meets Primary Efficacy Endpoint, Demonstrating Robust LH Suppression with 6-Month Dosing Interval of leuprolide mesylate
listed on the Taipei Exchange (TPEx: 6576). Foresee's R&D efforts are focused on two key areas, namely its unique Stabilized Injectable Formulation (SIF) long-acting injectable (LAI) technology with derived drug products targeting specialty markets and secondly, its transformative preclinical and clinical
More news about: Foresee Pharmaceuticals Co., Ltd.
Dec 18, 2025, 10:00 ET National Safety Council, NCCCO Foundation Launch Free Tool to Help Prevent Workplace Fatalities
SIF Prevention Model. It is designed for owners, executive leaders and safety professionals.It evaluates seven key areas that shape an organization's
More news about: National Safety Council
Dec 09, 2025, 08:01 ET US SIF's 30th Anniversary "Trends Report" Finds Sustainable Investing Asset Base Holding Amid Political Headwinds
https://www.ussif.org US SIF is supported in its work by the US SIF Foundation, a 501(C)(3) organization that undertakes educational and research activities to advance the mission of US SIF, including offering trainings for advisors and other financial professionals
More news about: US Sustainable Investment Forum
Nov 18, 2025, 11:06 ET Fiserv, Inc. (FI) Faces Lawmakers' Scrutiny After Admission to Objectively Difficult-to-Achieve Guidance Assumptions, "'Abysmal'" Q3 2025 Results - Hagens Berman
company's financial status." The probe follows the filing of a securities fraud class action styled Cypanga Sicav SIF v. Fiserv, Inc., et al., No. 2:25-cv-01716 (E.D. Wis.), after investors saw the price of their shares crater 47% on October 29, 2025 amid the company's
More news about: Hagens Berman Sobol Shapiro LLP
Nov 07, 2025, 10:37 ET Fiserv, Inc. (FI) Faces Securities Class Action Amid "'Abysmal'" Q3 2025 Results, Admits Objectively Difficult-to-Achieve July 2025 Guidance Assumptions - Hagens Berman
FRANCISCO, Nov. 7, 2025 /PRNewswire/ -- A securities fraud class action styled Cypanga Sicav SIF v. Fiserv, Inc., et al., No. 2:25-cv-01716 (E.D. Wis.), has been filed in the wake of a 47% crash in the price of Fiserv, Inc. (NYSE: FI)
More news about: Hagens Berman Sobol Shapiro LLP
Nov 05, 2025, 08:40 ET Fiserv, Inc. (FI) Faces Securities Class Action Amid "'Abysmal'" Q3 2025 Results, Admits Objectively Difficult-to-Achieve July 2025 Guidance Assumptions - Hagens Berman
FRANCISCO, Nov. 5, 2025 /PRNewswire/ -- A securities fraud class action styled Cypanga Sicav SIF v. Fiserv, Inc., et al., No. 2:25-cv-01716 (E.D. Wis.), has been filed in the wake of a 47% crash in the price of Fiserv, Inc. (NYSE: FI)
More news about: Hagens Berman Sobol Shapiro LLP
Oct 13, 2025, 08:00 ET New Investor Guide Launches to De-Risk Energy Transition Projects on Indigenous Lands
About: US Sustainable Investment ForumUS SIF is the leading capital markets sustainable investing network in the U.S., with members representing $5 trillion in assets under management or advisement. US SIF works to ensure that the U.S. capital markets play an active role in
More news about: US Sustainable Investment Forum
Sep 23, 2025, 07:00 ET Revyve Secures €24 Million Funding to Boost Egg-Replacing Yeast Proteins
positioned to grow into a global leader. We look forward to supporting their journey." said Hanna Zwietering, ABN AMRO SIF Senior Investment Manager.Lisette Kersting-van der Boog, Senior Investment Manager of Invest-NL adds: "With their
More news about: Revyve